Investing News NetworkYour trusted source for investing success

arbutus biopharma

5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent

5 Top NASDAQ Biotech and Pharma Stocks: IVERIC Up 350 Percent

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Melinta Leads

Arbutus Biopharma Gets Green Light for Phase 1a/1b Clinical Trial

5 Top Weekly NASDAQ Biotech Stocks: MannKind Soars 83 Percent

Alnylam Pharma Receives FDA Approval for Onpattro

Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis

5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top

Arbutus Announces Corporate Update and Year-End 2017 Financial Results

Arbutus Enters Exclusivity Agreement with Roivant Sciences

5 Top NASDAQ Biotech Stocks: Cerulean Pharma gained 118.42 percent

Share Purchase Plan Offer Booklet

Strong Leach Recoveries and Low Impurities

High Grade Cu-Au at Surface Delivers New Targets at Mankayan

Juggernaut Closes $1,100,000 from Institutions and Accredited Investors

Triumph Gold's Executive Chairman Discusses Utah Silver-Gold Acquisition and Exploration Strategy in New INN CEO Insights Interview

Quimbaya Gold

Asara Resources

International Lithium Corp.

Syntheia

Sun Summit Minerals

Metals Australia

MARKETS

COMMODITIES

CURRENCIES